ARTV

ARTIVA BIOTHERAPEUTICS INC

ARTV·04317A107·US·Common Stock·Healthcare - Biotechnology-Activist

ARTV (ARTIVA BIOTHERAPEUTICS INC) is held by 30 institutional investors as of Q1 2026. Largest holders: RA CAPITAL MANAGEMENT, L.P. ($63.5M), FRANKLIN RESOURCES INC ($3.4M), BlackRock, Inc. ($1.4M). Net institutional sentiment: Mixed.

30
Holders
Avg rating(6 Elite)
$75.9M
Total Value
46% (32)
Fund Consensus
11 buying - 13 selling
ARTVSmart Money Verdict
View all
Held by 30 funds
6 elite
Who's Trading
ActivistRA Capital Management, L.P.RA Capital Management, L.P.36.6%Jun 15, 2026
ActivistGCGC Corp12.3%May 28, 2026
ActivistVIKING GLOBAL INVESTORS LPVIKING GLOBAL INVESTORS LP5.4%May 18, 2026
ActivistRA Capital Management, L.P.RA Capital Management, L.P.33.7%May 13, 2026
InsiderAFAslan FredSell $19KDec 15, 2025
InsiderAFAslan FredSell $22KNov 17, 2025
InsiderAFAslan FredSell $153KOct 17, 2025
InsiderAFAslan FredSell $70KAug 15, 2025
ActivistBlackRock, Inc.BlackRock, Inc.2.0%Jul 16, 2025
ActivistVGvenBio Global Strategic Fund III, L.P.4.9%May 15, 2025
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Unchanged
9.9M$63.5M0.7%-31.19%
0
Unchanged
520,327$3.4M0.0%-31.19%
0
Increased
213,388(+0.4%)$1.4M0.0%+2.79%
17
New
207,686$1.3M0.0%+76.23%
39
Unchanged
194,108$1.3M0.0%-31.19%
0
Decreased
123,270(-43.2%)$793,8590.0%+555.78%
0
Decreased
115,041(-20.6%)$740,8640.0%+153.75%
0
Increased
101,695(+0.6%)$655,4510.0%-15.55%
17
Unchanged
100,000$644,0000.0%-31.19%
0
Decreased
80,038(-31.1%)$515,4450.0%+190.20%
0
Decreased
39,496(-2.9%)$254,3540.0%+130.62%
0
Unchanged
35,824$230,7070.0%-19.71%
0
New
32,810$211,2960.0%+76.23%
32
New
30,702$197,7210.0%+76.23%
32
New
21,581$138,9820.0%+76.23%
31
New
20,370$131,1830.0%+76.23%
34
New
20,270$130,5390.0%+76.23%
31
Decreased
16,377(-39.5%)$105,4680.0%+6.95%
0
New
15,870$102,2030.0%+76.23%
33
New
12,208$78,6200.0%+76.23%
33

Showing 1-20 of 32

1 / 2

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used